A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Psychiatry

• Publication date

  2008-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/appi.ajp.2007.07091440PMID 18316422PMCID PMC3945728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims.

  2009cited by this paper
• Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.

  2007cited by this paper
• Practice guideline for the treatment of patients with obsessive-compulsive disorder.

  2007cited by this paper
• An open clinical trial of cognitive-behaviour therapy in children and adolescents with obsessive-compulsive disorder administered in regular outpatient clinics.

  2007cited by this paper
• Response versus remission in obsessive-compulsive disorder.

  2006cited by this paper
• Treatment of obsessive-compulsive disorder by U.S. psychiatrists.

  2006cited by this paper
• A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

  2006cited by this paper
• A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

  2006cited by this paper
• Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: are there differences?

  2005cited by this paper
• Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.

  2005cited by this paper
• Measuring Change in OCD: Sensitivity of the Obsessive-Compulsive Inventory-Revised

  2005cited by this paper
• Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.

  2004cited by this paper
• Escitalopram versus citalopram: the surprising role of the R-enantiomer

  2004cited by this paper
• Physical health monitoring of patients with schizophrenia.

  2004cited by this paper
• ADDING COGNITIVE THERAPY ELEMENTS TO EXPOSURE THERAPY FOR OBSESSIVE COMPULSIVE DISORDER: A CONTROLLED STUDY

  2004cited by this paper
• Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial.

  2004cited by this paper
• Long-Term Efficacy of Exposure and Ritual Prevention Therapy and Serotonergic Medications for Obsessive-Compulsive Disorder

  2003cited by this paper
• Exposure and ritual prevention for obsessive-compulsive disorder: effects of intensive versus twice-weekly sessions.

  2003cited by this paper
• The Obsessive-Compulsive Inventory: development and validation of a short version.

  2002influential reference
• Addition of cognitive‐behaviour therapy for obsessive‐compulsive disorder patients non‐responding to fluoxetine

  2002cited by this paper
• Cognitive-Behavioral Therapy With and Without Medication in the Treatment of Obsessive-Compulsive Disorder

  2002cited by this paper
• Escitalopram: A Second-Generation SSRI

  2002cited by this paper
• The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization.

  2001cited by this paper
• Cognitive-behavior therapy of obsessive-compulsive disorder in private practice: an effectiveness study.

  2001cited by this paper
• The relationship between obsessive–compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study

  2001cited by this paper
• Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

  2001cited by this paper
• Behavioral treatment of obsessive-compulsive disorder in a naturalistic setting

  2000cited by this paper
• A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.

  2000cited by this paper
• Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.

  1999cited by this paper
• A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.

  1999cited by this paper
• Sensitive and selective liquid chromatographic assay of memantine in plasma with fluorescence detection after pre-column derivatization.

  1999cited by this paper
• Analysis of longitudinal data

  1998cited by this paper
• Structured Clinical Interview for DSM-IV Axis I Disorders

  1997cited by this paper
• Controlled trial of exposure and response prevention in obsessive–compulsive disorder

  1997cited by this paper
• Mastery of Obsessive-Compulsive Disorder: A Cognitive-Behavioral Approach Therapist Guide

  1997cited by this paper
• Treatment of obsessive-compulsive disorder. The Expert Consensus Panel for obsessive-compulsive disorder.

  1997cited by this paper
• Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.

  1995cited by this paper
• Statistical Methods for Survival Data Analysis

  1994cited by this paper
• Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder.

  1993cited by this paper
• Reanalysis of The National Institute of Mental Health Treatment of Depression Collaborative Research Program General Effectiveness Report

  1993cited by this paper
• Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.

  1993influential reference
• Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling.

  1991cited by this paper
• The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

  1989cited by this paper
• Determination of fluvoxamine in human plasma by high-performance liquid chromatography with ultraviolet detection.

  1989cited by this paper
• The Yale-Brown Obsessive Compulsive Scale. II. Validity.

  1989cited by this paper
• The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability

  1989cited by this paper
• Statistical Methods for Survival Data Analysis

  1981cited by this paper
• Assessment of social adjustment by patient self-report.

  1976influential reference
• A sensitive GLC method for the determination of imipramine and desmethylimipramine using a nitrogen detector.

  1975cited by this paper
• Treatment of Chronic Obsessive-Compulsive Neurosis by in-vivo Exposure

  1975cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper
• The assessment of anxiety states by rating.

  1959cited by this paper

• Neuromodulation to Augment Cognitive-behaviour Therapy for Obsessive-compulsive Disorder

  2026cites this paper
• A cross-cultural incremental effects meta-analysis of acceptance and commitment therapy for depression: does targeting depression even matter?

  2026cites this paper
• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 International Guidelines for the Management of Patients with Obsessive-Compulsive Disorder

  2026cites this paper
• Clinical practice guidelines for obsessive-compulsive disorder: 2025 update

  2026influential citation
• A systematic review of potential publication bias in U.S. National Institutes of Health-funded trials of psychological treatments for obsessive-compulsive disorder in adults

  2025cites this paper
• The effect of treatment on the quality of life of patients with obsessive-compulsive disorder: systematic review and meta-analysis.

  2025cites this paper
• A network analysis of how obsessive-compulsive symptoms change during exposure and response prevention treatment

  2025cites this paper
• Neurochemical mechanisms of deep brain stimulation

  2025cites this paper
• Psychometric Properties of the Yale-Brown Obsessive Compulsive Scale-II Self-Report

  2024cites this paper
• Convergent molecular signatures across eating disorders and obsessive-compulsive disorder in the human brain

  2024cites this paper
• A protocol for a randomized controlled trial of exposure and response prevention for veterans with obsessive compulsive disorder.

  2024cites this paper
• Advances in the Management of Pediatric OCD: Predictors, Moderators, and New Frontiers

  2024cites this paper
• Psychotherapy for Treatment-Resistant Obsessive-Compulsive Disorder

  2023cites this paper
• Anxiety during the long-term course of obsessive-compulsive disorder.

  2023cites this paper
• Obsessive–Compulsive Disorder in Sports–Beyond Superstitions

  2023cites this paper
• Changes in Brain Network Connections after Exposure and Response Prevention Therapy for OCD in Adolescents and Adults.

  2023cites this paper
• Brain Imaging in Psychiatry: Time to Move From Regions of Interest and Interpretive Analyses to Connectomes and Predictive Modeling?

  2023cites this paper
• Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive–compulsive disorder: A network meta‐analysis

  2023cites this paper
• Comparison of internet-based and face-to-face cognitive behavioral therapy for obsessive-compulsive disorder: A systematic review and network meta-analysis.

  2023cites this paper
• Exposure and response prevention versus stress management training for adults and adolescents with obsessive compulsive disorder: A randomized clinical trial.

  2023cites this paper
• Identifying trajectories of symptom change in adults with obsessive compulsive disorder receiving exposure and response prevention therapy.

  2023cites this paper
• The therapeutic alliance in cognitive-behavioral therapy for obsessive-compulsive disorder: A systematic review and meta-analysis

  2022cites this paper
• Quality of the therapeutic working alliance as a factor in intensive residential treatment of obsessive-compulsive disorder

  2022cites this paper
• The efficacy of brief strategic therapy in treating obsessive-compulsive disorder: a case series

  2022cites this paper
• Mental health burden of empty nose syndrome compared to chronic rhinosinusitis and chronic rhinitis

  2022cites this paper
• Is mindfulness-based intervention an effective treatment for people with obsessive-compulsive disorder? A systematic review and meta-analysis

  2022cites this paper
• Responsibility, probability, and severity of harm: An experimental investigation of cognitive factors associated with checking-related OCD.

  2022cites this paper
• Management of OCD: Focus on Psychotherapy

  2022cites this paper
• A Novel Insular/Orbital-Prelimbic Circuit That Prevents Persistent Avoidance in a Rodent Model of Compulsive Behavior.

  2022cites this paper
• Best practices for CBT treatment of taboo and unacceptable thoughts in OCD

  2022cites this paper
• Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation: A Randomized Clinical Trial.

  2022cites this paper
• Serotonin reuptake inhibitor-cognitive behavioural therapy-second generation antipsychotic combination for severe treatment-resistant obsessive-compulsive disorder. A prospective observational study

  2022influential citation
• Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder.

  2021cites this paper
• Exposure therapy in a virtual environment: Validation in obsessive compulsive disorder.

  2021cites this paper
• High-frequency neuromodulation improves obsessive–compulsive behavior

  2021cites this paper
• Knowledge and competency standards for specialized cognitive behavior therapy for adult obsessive-compulsive disorder.

  2021cites this paper
• Innovations in the Delivery of Exposure and Response Prevention for Obsessive-Compulsive Disorder.

  2021cites this paper
• Pharmacological and Psychotherapeutic Interventions for Management of Obsessive-compulsive Disorder in Adults: A Systematic Review and Network Meta-analysis.

  2021cites this paper
• Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder.

  2021cites this paper
• Treatment-specific associations between brain activation and symptom reduction following cognitive behavioral therapy in obsessive-compulsive disorder: A randomized fMRI trial.

  2021cites this paper
• Defining and Addressing Gaps in Care for Obsessive-Compulsive Disorder in the United States.

  2021cites this paper
• The effects of depression on the treatment of OCD in a residential sample.

  2020cites this paper
• A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Disorder on an Optimal Dose of SSRIs: A Randomized Controlled Trial in Iran

  2020cites this paper
• Treatment-Specific Associations Between Brain Activation and Symptom Reduction in OCD Following CBT: A Randomized fMRI Trial.

  2020cites this paper
• A randomized controlled trial of mindfulness-based cognitive therapy vs stress management training for obsessive-compulsive disorder.

  2020cites this paper
• The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap

  2020influential citation
• A systematic review of cognitive-behavioral therapy for pharmacotherapy treatment-resistant obsessive-compulsive disorder

  2020cites this paper
• Integrating Exposure and Response Prevention With a Mobile App to Treat Obsessive-Compulsive Disorder: Feasibility, Acceptability, and Preliminary Effects.

  2020cites this paper
• Mechanisms of harmful treatments for obsessive–compulsive disorder.

  2020cites this paper
• Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders

  2020cites this paper
• The two‐step task, avoidance, and OCD

  2020cites this paper
• A prospective study of intensive in-patient treatment for obsessive-compulsive disorder.

  2020cites this paper
• Changes in the daily life experience of patients with obsessive-compulsive disorder following mindfulness-based cognitive therapy: Looking beyond symptom reduction using ecological momentary assessment.

  2020cites this paper
• Prolonged avoidance training exacerbates OCD-like behaviors in a rodent model

  2020cites this paper
• What is the impact of pharmacotherapy on psychotherapy for obsessive-compulsive disorder?

  2020cites this paper
• A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.

  2019cites this paper
• Forests and Trees: Commentary on the Case of "Daniel"

  2019cites this paper
• Efficacy of cognitive behavioural therapy with medication for patients with obsessive-compulsive disorder: A multicentre randomised controlled trial in China.

  2019cites this paper
• Predictors of treatment outcome in OCD: An interpersonal perspective.

  2019cites this paper
• Obsessive–Compulsive Symptoms Are Associated With Increased Delay Discounting in a Novel Hand-Washing Task

  2019cites this paper
• Sudden gains in internet-based cognitive behavior therapy for obsessive-compulsive disorder

  2019cites this paper
• Indian guidelines on neurosurgical interventions in psychiatric disorders

  2019cites this paper
• Neurophysiological, cognitive-behavioral and neurochemical effects in practitioners of transcendental meditation - A literature review.

  2019cites this paper
• The study of active avoidance: A platform for discussion.

  2019cites this paper
• Refining the Analysis of Mechanism–Outcome Relationships for Anxiety Treatment: A Preliminary Investigation Using Mixed Models

  2019cites this paper
• Exposure and response prevention for obsessive-compulsive disorder: A review and new directions

  2019cites this paper
• Pediatric OCD

  2019cites this paper
• Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom.

  2019cites this paper
• Integrating Cognitive Behavioral Therapy and Medications for the Treatment of Obsessive-Compulsive Disorder

  2019cites this paper
• Cost-Effectiveness of Treatment Alternatives for Treatment-Refractory Pediatric Obsessive-Compulsive Disorder.

  2019cites this paper
• Obsessive compulsive disorder (OCD): Current treatments and a framework for neurotherapeutic research.

  2019cites this paper
• A Meta-analysis to Guide the Enhancement of CBT for Childhood Anxiety: Exposure Over Anxiety Management

  2019cites this paper
• What matters more? Common or specific factors in cognitive behavioral therapy for OCD: Therapeutic alliance and expectations as predictors of treatment outcome.

  2018cites this paper
• CBT-Plus: A meta-analysis of cognitive behavioral therapy augmentation strategies for obsessive-compulsive disorder

  2018cites this paper
• Obsessive-Compulsive Disorder

  2018cites this paper
• A Complex Case of Obsessive-Compulsive Disorder (OCD)

  2018cites this paper
• Behavioral avoidance predicts treatment outcome with exposure and response prevention for obsessive–compulsive disorder

  2018cites this paper
• Mental Health and Cognitive Behavioral Therapy: Advanced Issues and Approaches

  2018cites this paper
• Efficacy of inhibitory learning theory-based exposure and response prevention and selective serotonin reuptake inhibitor in obsessive-compulsive disorder management: A treatment comparison

  2018cites this paper
• Treatment Resistance in Obsessive-Compulsive Disorder

  2018cites this paper
• A randomized controlled study of brief family-based intervention in obsessive compulsive disorder.

  2018cites this paper
• OCD Spectrum Disorders

  2018cites this paper
• Obsessive-Compulsive and Related Disorders in Older Age

  2018cites this paper
• Cognitive–behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review

  2017cites this paper
• Mindfulness-based cognitive therapy as an augmentation treatment for obsessive-compulsive disorder.

  2017cites this paper
• Effectiveness of Cognitive Behavioral Therapy for Individuals with Autism Spectrum Disorders and Comorbid Obsessive-Compulsive Disorder: A Review of the Research

  2017cites this paper
• Tryptophan overloading activates brain regions involved with cognition, mood and anxiety.

  2017cites this paper
• Development and Validation of the Distress Tolerance Questionnaire (DTQ)

  2017cites this paper
• Early response is predictive of outcome in intensive behavioral treatment for obsessive compulsive disorder

  2017cites this paper
• Management of Treatment-Resistant Obsessive-Compulsive Disorder

  2017cites this paper
• Clinical practice guidelines for Obsessive-Compulsive Disorder

  2017cites this paper
• The Importance of Problem-Focused Treatments: A Meta-Analysis of Anxiety Treatments

  2017cites this paper
• Biological Models and Treatments for OCD in Adults

  2017cites this paper
• Neuromodulation for Psychiatric Disorders

  2017cites this paper
• Cognitive-behavioral therapy as an effective, safe, and acceptable intervention for OCD during pregnancy

  2017cites this paper
• Anxiety Disorders: Evidence-Based Integrated Biopsychosocial Treatment

  2017cites this paper
• Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis

  2016cites this paper
• Efficacy of mindfulness-integrated cognitive behavior therapy in patients with predominant obsessions

  2016influential citation
• Cognitive Mediation of Symptom Change in Exposure and Response Prevention for Obsessive-Compulsive Disorder.

  2016cites this paper
• Guidelines on the management of co-occurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings.

  2016cites this paper